TrialImmunology2023

Ability of SpikoGen®, an Advax-CpG adjuvanted recombinant spike protein vaccine, to induce cross-neutralising antibodies against SARS-CoV-2 variants.

Yoshikazu Honda-Okubo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.